Ono Shin, Nakai Takahiko, Kuroda Hirofumi, Miyatake Ryuta, Horino Yoshikazu, Abe Hitoshi, Umezaki Masahito, Oyama Hiroshi
Genome Biotechnology Laboratory, Kanazawa Institute of Technology, Hakusan, 924-0838, Japan.
Graduate School of Science and Engineering, University of Toyama, Toyama, 930-8555, Japan.
Biopolymers. 2016 Nov 4;106(4):521-30. doi: 10.1002/bip.22790.
Diphenyl (α-aminoalkyl)phosphonates act as mechanism-based inhibitors against serine proteases by forming a covalent bond with the hydroxy group of the active center Ser residue. Because the covalent bond was found to be broken and replaced by 2-pyridinaldoxime methiodide (2PAM), we employed a peptidyl derivative bearing diphenyl 1-amino-2-phenylethylphosphonate moiety (Phe(p) (OPh)2 ) to target the active site of chymotrypsin and to selectively anchor to Lys175 in the vicinity of the active site. Previously, it was reported that the configuration of the α-carbon of phosphorus in diphenyl (α-aminoalkyl)phosphonates affects the inactivation reaction of serine proteases, i.e., the (R)-enantiomeric diphenyl phosphonate is comparable to l-amino acids and it effectively reacts with serine proteases, whereas the (S)-enantiomeric form does not. In this study, we evaluated the stereochemical effect of the phosphonate moiety on the selective chemical modification. Epimeric dipeptidyl derivatives, Ala-(R or S)-Phe(p) (OPh)2 , were prepared by separation with RP-HPLC. A tripeptidyl (R)-epimer (Ala-Ala-(R)-Phe(p) (OPh)2 ) exhibited a more potent inactivation ability against chymotrypsin than the (S)-epimer. The enzyme inactivated by the (R)-epimer was more effectively reactivated with 2PAM than the enzyme inactivated by the (S)-epimer. Finally, N-succinimidyl (NHS) active ester derivatives, NHS-Suc-Ala-Ala- (R or S)-Phe(p) (OPh)2 , were prepared, and we evaluated their action when modifying Lys175 in chymotrypsin. We demonstrated that the epimeric NHS derivative that possessed the diphenyl phosphonate moiety with the (R)-configuration effectively modified Lys175 in chymotrypsin, whereas that with the (S)-configuration did not. These results demonstrate the utility of peptidyl derivatives that bear an optically active diphenyl phosphonate moiety as affinity labeling probes in protein bioconjugation. © 2015 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 521-530, 2016.
二苯基(α-氨基烷基)膦酸酯通过与活性中心丝氨酸残基的羟基形成共价键,作为基于机制的丝氨酸蛋白酶抑制剂。由于发现共价键断裂并被2-吡啶甲醛肟甲基碘(2PAM)取代,我们采用了带有二苯基1-氨基-2-苯乙基膦酸酯部分(Phe(p)(OPh)2)的肽基衍生物来靶向胰凝乳蛋白酶的活性位点,并选择性地锚定在活性位点附近的Lys175上。此前有报道称,二苯基(α-氨基烷基)膦酸酯中磷的α-碳构型会影响丝氨酸蛋白酶的失活反应,即(R)-对映体二苯基膦酸酯与L-氨基酸相当,能有效地与丝氨酸蛋白酶反应,而(S)-对映体形式则不能。在本研究中,我们评估了膦酸酯部分的立体化学效应在选择性化学修饰中的作用。通过反相高效液相色谱分离制备了差向异构二肽基衍生物Ala-(R或S)-Phe(p)(OPh)2。三肽基(R)-差向异构体(Ala-Ala-(R)-Phe(p)(OPh)2)对胰凝乳蛋白酶的失活能力比(S)-差向异构体更强。与被(S)-差向异构体失活的酶相比,被(R)-差向异构体失活的酶用2PAM重新激活的效果更好。最后,制备了N-琥珀酰亚胺基(NHS)活性酯衍生物NHS-Suc-Ala-Ala-(R或S)-Phe(p)(OPh)2,并评估了它们在修饰胰凝乳蛋白酶中Lys175时的作用。我们证明,具有(R)-构型二苯基膦酸酯部分的差向异构NHS衍生物能有效地修饰胰凝乳蛋白酶中的Lys175,而具有(S)-构型的则不能。这些结果证明了带有光学活性二苯基膦酸酯部分的肽基衍生物作为蛋白质生物共轭中亲和标记探针的实用性。©2015威利期刊公司。生物聚合物(肽科学)106:521 - 530,2016。